SERB Pharmaceuticals is a Global pharmaceutical company and a pivotal player in the research, development, manufacturing, supply, and distribution of crisis-related Chemical, Biological, Radiological, and Nuclear (CBRN) medical countermeasures. They have the broadest antidote portfolio in the world, including countermeasures for nerve agents, cyanide, heavy metal poisoning, and radiation; effectively addressing a wide spectrum of major risks for public health. SERB is one of the few companies that can manufacture polyclonal antibodies at a commercial scale and suitable for market authorisation in all territories. #proud to save lives